Global Orotic Aciduria Market Size, Share, Growth Analysis Report - Forecast 2034
Orotic Aciduria Market By Drug Type (Uridine Monophosphate, Cytidine Monophosphate, Others), By Type (Type II, Type I), and By Region: Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2025 - 2034
Category: Pharmaceutical Report Format : PDF
Pages: 216 Report Code: ZMR-7259
Published Date: Sep-2025 Status : Published
| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 387.22 Million | USD 728.7 Million | 6.53% | 2024 |
Table Of Content
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market research methodology
- Chapter 2. Executive Summary
- 2.1 Global Orotic Aciduria Market, (2023 - 2030) (USD Million)
- 2.2 Global Orotic Aciduria Market : snapshot
- Chapter 3. Global Orotic Aciduria Market - Industry Analysis
- 3.1 Orotic Aciduria Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing awareness rate to drive market growth
- 3.3 Market Restraints
- 3.3.1. Rarity rate to limit market growth
- 3.4 Market Opportunities
- 3.4.1. Investments in personalized medicine approach to provide several growth opportunities
- 3.5 Market Challenges
- 3.5.1. Inaccurate diagnosis to challenge the market expansion
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market attractiveness analysis By Drug Type
- 3.7.2 Market attractiveness analysis By Type
- Chapter 4. Global Orotic Aciduria Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Orotic Aciduria Market: company market share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, cullaborations, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Orotic Aciduria Market - Drug Type Analysis
- 5.1 Global Orotic Aciduria Market overview: By Drug Type
- 5.1.1 Global Orotic Aciduria Market share, By Drug Type, 2022 and 2030
- 5.2 Uridine Monophosphate
- 5.2.1 Global Orotic Aciduria Market by Uridine Monophosphate, 2023 - 2030 (USD Million)
- 5.3 Cytidine Monophosphate
- 5.3.1 Global Orotic Aciduria Market by Cytidine Monophosphate, 2023 - 2030 (USD Million)
- 5.4 Others
- 5.4.1 Global Orotic Aciduria Market by Others, 2023 - 2030 (USD Million)
- 5.1 Global Orotic Aciduria Market overview: By Drug Type
- Chapter 6. Global Orotic Aciduria Market - Type Analysis
- 6.1 Global Orotic Aciduria Market overview: By Type
- 6.1.1 Global Orotic Aciduria Market share, By Type, 2022 and 2030
- 6.2 Type II
- 6.2.1 Global Orotic Aciduria Market by Type II, 2023 - 2030 (USD Million)
- 6.3 Type I
- 6.3.1 Global Orotic Aciduria Market by Type I, 2023 - 2030 (USD Million)
- 6.1 Global Orotic Aciduria Market overview: By Type
- Chapter 7. Orotic Aciduria Market - Regional Analysis
- 7.1 Global Orotic Aciduria Market Regional Overview
- 7.2 Global Orotic Aciduria Market Share, by Region, 2022 & 2030 (USD Million)
- 7.3. North America
- 7.3.1 North America Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.3.1.1 North America Orotic Aciduria Market, by Country, 2023 - 2030 (USD Million)
- 7.3.1 North America Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.4 North America Orotic Aciduria Market, by Drug Type, 2023 - 2030
- 7.4.1 North America Orotic Aciduria Market, by Drug Type, 2023 - 2030 (USD Million)
- 7.5 North America Orotic Aciduria Market, by Type, 2023 - 2030
- 7.5.1 North America Orotic Aciduria Market, by Type, 2023 - 2030 (USD Million)
- 7.4. Europe
- 7.4.2 Europe Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.4.2.1 Europe Orotic Aciduria Market, by Country, 2023 - 2030 (USD Million)
- 7.4.2 Europe Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.4 Europe Orotic Aciduria Market, by Drug Type, 2023 - 2030
- 7.4.1 Europe Orotic Aciduria Market, by Drug Type, 2023 - 2030 (USD Million)
- 7.5 Europe Orotic Aciduria Market, by Type, 2023 - 2030
- 7.5.1 Europe Orotic Aciduria Market, by Type, 2023 - 2030 (USD Million)
- 7.5. Asia Pacific
- 7.5.3 Asia Pacific Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.5.3.1 Asia Pacific Orotic Aciduria Market, by Country, 2023 - 2030 (USD Million)
- 7.5.3 Asia Pacific Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.4 Asia Pacific Orotic Aciduria Market, by Drug Type, 2023 - 2030
- 7.4.1 Asia Pacific Orotic Aciduria Market, by Drug Type, 2023 - 2030 (USD Million)
- 7.5 Asia Pacific Orotic Aciduria Market, by Type, 2023 - 2030
- 7.5.1 Asia Pacific Orotic Aciduria Market, by Type, 2023 - 2030 (USD Million)
- 7.6. Latin America
- 7.6.4 Latin America Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.6.4.1 Latin America Orotic Aciduria Market, by Country, 2023 - 2030 (USD Million)
- 7.6.4 Latin America Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.4 Latin America Orotic Aciduria Market, by Drug Type, 2023 - 2030
- 7.4.1 Latin America Orotic Aciduria Market, by Drug Type, 2023 - 2030 (USD Million)
- 7.5 Latin America Orotic Aciduria Market, by Type, 2023 - 2030
- 7.5.1 Latin America Orotic Aciduria Market, by Type, 2023 - 2030 (USD Million)
- 7.7. The Middle-East and Africa
- 7.7.5 The Middle-East and Africa Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.7.5.1 The Middle-East and Africa Orotic Aciduria Market, by Country, 2023 - 2030 (USD Million)
- 7.7.5 The Middle-East and Africa Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 7.4 The Middle-East and Africa Orotic Aciduria Market, by Drug Type, 2023 - 2030
- 7.4.1 The Middle-East and Africa Orotic Aciduria Market, by Drug Type, 2023 - 2030 (USD Million)
- 7.5 The Middle-East and Africa Orotic Aciduria Market, by Type, 2023 - 2030
- 7.5.1 The Middle-East and Africa Orotic Aciduria Market, by Type, 2023 - 2030 (USD Million)
- Chapter 8. Company Profiles
- 8.1 Alexion Pharmaceuticals
- 8.1.1 Overview
- 8.1.2 Financials
- 8.1.3 Product Portfolio
- 8.1.4 Business Strategy
- 8.1.5 Recent Developments
- 8.2 Sanofi Genzyme
- 8.2.1 Overview
- 8.2.2 Financials
- 8.2.3 Product Portfolio
- 8.2.4 Business Strategy
- 8.2.5 Recent Developments
- 8.3 Roche Holding AG
- 8.3.1 Overview
- 8.3.2 Financials
- 8.3.3 Product Portfolio
- 8.3.4 Business Strategy
- 8.3.5 Recent Developments
- 8.4 Novartis AG
- 8.4.1 Overview
- 8.4.2 Financials
- 8.4.3 Product Portfolio
- 8.4.4 Business Strategy
- 8.4.5 Recent Developments
- 8.5 Pfizer Inc.
- 8.5.1 Overview
- 8.5.2 Financials
- 8.5.3 Product Portfolio
- 8.5.4 Business Strategy
- 8.5.5 Recent Developments
- 8.6 Shire
- 8.6.1 Overview
- 8.6.2 Financials
- 8.6.3 Product Portfolio
- 8.6.4 Business Strategy
- 8.6.5 Recent Developments
- 8.7 BioMarin Pharmaceutical Inc.
- 8.7.1 Overview
- 8.7.2 Financials
- 8.7.3 Product Portfolio
- 8.7.4 Business Strategy
- 8.7.5 Recent Developments
- 8.8 Vertex Pharmaceuticals Incorporated
- 8.8.1 Overview
- 8.8.2 Financials
- 8.8.3 Product Portfolio
- 8.8.4 Business Strategy
- 8.8.5 Recent Developments
- 8.9 Ultragenyx Pharmaceutical Inc.
- 8.9.1 Overview
- 8.9.2 Financials
- 8.9.3 Product Portfolio
- 8.9.4 Business Strategy
- 8.9.5 Recent Developments
- 8.10 Horizon Therapeutics
- 8.10.1 Overview
- 8.10.2 Financials
- 8.10.3 Product Portfolio
- 8.10.4 Business Strategy
- 8.10.5 Recent Developments
- 8.11 CSL Behring
- 8.11.1 Overview
- 8.11.2 Financials
- 8.11.3 Product Portfolio
- 8.11.4 Business Strategy
- 8.11.5 Recent Developments
- 8.12 Sarepta Therapeutics
- 8.12.1 Overview
- 8.12.2 Financials
- 8.12.3 Product Portfolio
- 8.12.4 Business Strategy
- 8.12.5 Recent Developments
- 8.13 Regeneron Pharmaceuticals Inc.
- 8.13.1 Overview
- 8.13.2 Financials
- 8.13.3 Product Portfolio
- 8.13.4 Business Strategy
- 8.13.5 Recent Developments
- 8.14 Moderna Inc.
- 8.14.1 Overview
- 8.14.2 Financials
- 8.14.3 Product Portfolio
- 8.14.4 Business Strategy
- 8.14.5 Recent Developments
- 8.15 bluebird bio
- 8.15.1 Overview
- 8.15.2 Financials
- 8.15.3 Product Portfolio
- 8.15.4 Business Strategy
- 8.15.5 Recent Developments
- 8.16 Sangamo Therapeutics
- 8.16.1 Overview
- 8.16.2 Financials
- 8.16.3 Product Portfolio
- 8.16.4 Business Strategy
- 8.16.5 Recent Developments
- 8.17 Amicus Therapeutics
- 8.17.1 Overview
- 8.17.2 Financials
- 8.17.3 Product Portfolio
- 8.17.4 Business Strategy
- 8.17.5 Recent Developments
- 8.18 Orchard Therapeutics
- 8.18.1 Overview
- 8.18.2 Financials
- 8.18.3 Product Portfolio
- 8.18.4 Business Strategy
- 8.18.5 Recent Developments
- 8.19 Abeona Therapeutics
- 8.19.1 Overview
- 8.19.2 Financials
- 8.19.3 Product Portfolio
- 8.19.4 Business Strategy
- 8.19.5 Recent Developments
- 8.20 PTC Therapeutics
- 8.20.1 Overview
- 8.20.2 Financials
- 8.20.3 Product Portfolio
- 8.20.4 Business Strategy
- 8.20.5 Recent Developments
- 8.21 Akcea Therapeutics
- 8.21.1 Overview
- 8.21.2 Financials
- 8.21.3 Product Portfolio
- 8.21.4 Business Strategy
- 8.21.5 Recent Developments
- 8.22 Catabasis Pharmaceuticals
- 8.22.1 Overview
- 8.22.2 Financials
- 8.22.3 Product Portfolio
- 8.22.4 Business Strategy
- 8.22.5 Recent Developments
- 8.23 Translate Bio
- 8.23.1 Overview
- 8.23.2 Financials
- 8.23.3 Product Portfolio
- 8.23.4 Business Strategy
- 8.23.5 Recent Developments
- 8.24 Homology Medicines
- 8.24.1 Overview
- 8.24.2 Financials
- 8.24.3 Product Portfolio
- 8.24.4 Business Strategy
- 8.24.5 Recent Developments
- 8.25 and Harmony Biosciences.
- 8.25.1 Overview
- 8.25.2 Financials
- 8.25.3 Product Portfolio
- 8.25.4 Business Strategy
- 8.25.5 Recent Developments
- 8.1 Alexion Pharmaceuticals
Table Of Figures
- 1. Market research Type
- 2. Market research methodology
- 3. Global Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 4. Porter’s Five Forces Analysis
- 5. Global Orotic Aciduria Market attractiveness, By Drug Type
- 6. Global Orotic Aciduria Market attractiveness, By Type
- 7. Global Orotic Aciduria Market share by Drug Type, 2023 and 2030 (USD Million)
- 8. Global Orotic Aciduria Market by Uridine Monophosphate, 2023 - 2030 (USD Million)
- 9. Global Orotic Aciduria Market by Cytidine Monophosphate, 2023 - 2030 (USD Million)
- 10. Global Orotic Aciduria Market by Others, 2023 - 2030 (USD Million)
- 11. Global Orotic Aciduria Market share by Type, 2023 and 2030 (USD Million)
- 12. Global Orotic Aciduria Market by Type II, 2023 - 2030 (USD Million)
- 13. Global Orotic Aciduria Market by Type I, 2023 - 2030 (USD Million)
- 14. Global Orotic Aciduria Market share, by Region, 2023 and 2030
- 15. North America Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 16. Europe Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 17. Asia Pacific Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 18. Latin America Orotic Aciduria Market, 2023 - 2030 (USD Million)
- 19. The Middle-East and Africa Orotic Aciduria Market, 2023 - 2030 (USD Million)
Table Of Tables
- 1. Global Orotic Aciduria Market: Snapshot
- 2. Drivers of the Orotic Aciduria Market: impact analysis
- 3. North America Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 4. North America Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 5. U.S. Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 6. U.S. Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 7. Canada Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 8. Canada Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 9. Europe Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 10. Europe Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 11. Germany Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 12. Germany Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 13. France Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 14. France Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 15. U.K. Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 16. U.K. Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 17. Italy Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 18. Italy Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 19. Spain Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 20. Spain Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 21. Rest of Europe Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 22. Rest of Europe Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 23. Asia Pacific Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 24. Asia Pacific Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 25. China Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 26. China Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 27. Japan Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 28. Japan Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 29. India Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 30. India Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 31. South Korea Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 32. South Korea Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 33. South-East Asia Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 34. South-East Asia Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 35. Rest of Asia Pacific Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 36. Rest of Asia Pacific Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 37. Latin America Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 38. Latin America Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 39. Brazil Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 40. Brazil Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 41. Mexico Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 42. Mexico Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 43. Rest of Latin America Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 44. Rest of Latin America Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 45. The Middle-East and Africa Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 46. The Middle-East and Africa Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 47. GCC Countries Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 48. GCC Countries Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 49. South Africa Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 50. South Africa Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
- 51. Rest of Middle-East Africa Orotic Aciduria Market revenue, By Drug Type, 2023 - 2030 (USD Million)
- 52. Rest of Middle-East Africa Orotic Aciduria Market revenue, By Type, 2023 - 2030 (USD Million)
Methodology
FrequentlyAsked Questions
Orotic aciduria is also known as hereditary orotic aciduria. It is a rare genetic condition that tends to impact the metabolism of pyrimidine which is a building block for important nucleic acids such as Deoxyribonucleic acid and ribonucleic acid (RNA).
The global orotic aciduria market is expected to grow due to rising awareness of rare genetic disorders, advancements in diagnostic techniques, increasing research on metabolic diseases, and growing government support for orphan drug development.
According to a study, the global orotic aciduria market size was worth around USD 387.22 Million in 2024 and is expected to reach USD 728.7 Million by 2034.
The global orotic aciduria market is expected to grow at a CAGR of 6.53% during the forecast period.
The global orotic aciduria market is projected to be dominated by North America in the coming years. It must be noted that the condition is extremely rare and there is no concrete information to conclude which region has the largest set of patients.
Leading players in the global orotic aciduria market include Alexion Pharmaceuticals, Sanofi Genzyme, Roche Holding AG, Novartis AG, Pfizer Inc., Shire, BioMarin Pharmaceutical Inc., Vertex Pharmaceuticals Incorporated, Ultragenyx Pharmaceutical Inc., Horizon Therapeutics, CSL Behring, Sarepta Therapeutics, Regeneron Pharmaceuticals Inc., Moderna, Inc., bluebird bio, Sangamo Therapeutics, Amicus Therapeutics, Orchard Therapeutics, Abeona Therapeutics, PTC Therapeutics, Akcea Therapeutics, Catabasis Pharmaceuticals, Translate Bio, Homology Medicines, Harmony Biosciences., among others.
The report explores crucial aspects of the orotic aciduria market, including a detailed discussion of existing growth factors and restraints, while also examining future growth opportunities and challenges that impact the market.
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed